Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alglucosidase alfa in infantile-onset Pompe disease
NCT00486889Phase 4Completed
- Sponsor
- Sanofi
- Start
- Aug 2008
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
A Phase 4 trial of alglucosidase alfa in Pompe disease, sponsored by Sanofi. Started Aug 2008; status: completed.
02
Drugs
alglucosidase alfa
03
Conditions
Pompe disease
Beyond the preview
Go deeper on NCT00486889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00486889.